# A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

> **NCT00092859** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1500 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** MK0557

## Key facts

- **NCT ID:** NCT00092859
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2017-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092859, "A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*